Microtubule-organizing centers move from centrosomes to the nuclear envelope during muscle development. The KASH protein Nesprin-1a recruits pericentriolar material to the surface of myotube nuclei, where it nucleates microtubules to ensure even spacing of nuclei within the developing myotube.
Mammalian skeletal muscles form when hundreds of myoblasts fuse into multinucleated myotubes, which differentiate into myofibers. The position of nuclei throughout muscle development is tightly controlled. Defects in nuclear positioning can lead to Emery-Dreifuss muscular dystrophy and centronuclear myopathies [1, 2] . At least five mechanistically and temporally distinct nuclear movements occur during skeletal muscle development [3] . Shortly after a myoblast fuses with a multinucleated myotube, the nucleus rapidly migrates toward the center of the syncytium. Then, myotube nuclei spread apart. A key factor in the switch from myoblast to myotube nuclear behavior is a fundamental change in the microtubuleorganizing center (MTOC). In myoblasts, microtubules are nucleated from the centrosome. In myotubes, the cytoplasmic surface of the nuclear envelope serves as the major MTOC of the cell [4, 5] . Switching of the MTOC from a centrosomal to a non-centrosomal location is a hallmark of differentiation [6] . An exciting report in this issue of Current Biology by Gimpel et al. [7] characterizes the mechanisms responsible for the recruitment of the MTOC to the cytoplasmic surface of the nuclei in developing myotubes and provides support for a new model for how nuclei are spaced apart in developing myotubes using microtubules nucleated from the cytoplasmic surface of the nuclear envelope.
The new microtubule-nucleation model for nuclear spreading requires Nesprin-1 at the surface of the nuclear envelope. Mammalian Nesprin-1 (encoded by the SYNE1 gene), its paralog Nesprin-2, and its orthologs ANC-1 in C. elegans and MSP-300 in Drosophila encode some of the largest proteins ever identified: the full-length isoforms approach a megaDalton in size [8] . These proteins contain actin-binding domains at their amino termini, long extended regions made mostly of spectrin-like repeats, and a carboxy-terminal KASH (Klarsicht, ANC-1 and Syne homology) domain that inserts into the outer nuclear membrane and interacts with SUN (Sad1, UNC-84 domain) proteins in the perinuclear space [8] . Thus, Nesprin-1 makes up the outer nuclear membrane half of LINC (linker of nucleoskeleton and cytoskeleton) complexes that bridge the nuclear envelope to connect the nucleus to the cytoskeleton.
There are many isoforms of Nesprin-1: 16 different 5' UTRs and 14 different 3' UTRs have been identified [9] . A few of these isoforms have been validated in vivo, including the Nesprin-1a isoform of 115 kDa, which contains its own 5' UTR, the last seven spectrin repeats, and the KASH domain [9] . Multiple labs have made mouse lines carrying Nesprin-1 mutations. Deletion of the KASH domain or a spectrin repeat near the carboxyl terminus of Nesprin-1 leads to nuclear positioning defects in skeletal muscles [10] [11] [12] . In contrast, mice with deletions in the amino-terminal actin-binding domains of Nesprin-1 have no obvious muscle defects [13] , suggesting that the carboxy-terminal regions of Nesprin-1 are sufficient for nuclear positioning in muscles. A mouse was recently generated with a specific deletion of the 5' UTR of Nesprin-1a, presumably leaving other Nesprin-1 isoforms intact. This mouse phenocopied the skeletal muscle nuclear positioning defect seen in Nesprin-1 KASH deletion mice, suggesting that the Nesprin-1a isoform mediates nuclear positioning in developing skeletal muscle [13] . In the new study, Gimpel et al. [7] therefore focused on the Nesprin-1a isoform. They first confirmed the recent results of others and showed that, shortly after myoblasts are induced to fuse together and form myotubes, the Nesprin-1a isoform was transcriptionally activated, highly expressed, and localized to the nuclear envelope [7, [13] [14] [15] . Thus, Nesprin-1a is expressed at the correct time and place to mediate nuclear positioning in myotubes.
To elucidate the mechanism for how Nesprin-1a mediates nuclear spreading in myotubes, Gimpel et al. [7] searched for potential Nesprin-1a-binding partners using a proximity assay called BioID [16] . They identified four centrosomal proteins, including pericentrin and Akap450, both of which have been shown to recruit the g-tubulin ring complex to nucleate microtubules [17] . In support of the BioID assays, Nesprin-1a, pericentrin, and Akap450 co-localized using super-resolution microscopy.
These findings led to a working model where Nesprin-1a recruits pericentriolar material to the cytoplasmic surface of the nuclear envelope to nucleate microtubules.
To test their model, Gimpel et al. [7] examined the genetic requirement of Nesprin-1a to recruit pericentrin and Akap450 to the nuclear envelope. siRNA knockdown of Nesprin-1 or both of its SUN partners led to a significant decrease of pericentrin at the nuclear envelope in cultured myotubes from two sources: primary mouse myoblasts or differentiated C2C12 cells. Similarly, both pericentrin and Akap450 failed to localize to the nuclear envelope of differentiated myoblasts when Nesprin-1 was deleted from C2C12 cells by CRISPR. As a useful tool, the authors induced expression of Nesprin-1a in these Nesprin-1-deficient C2C12 cells after differentiation into myotubes and were able to then recruit pericentrin and Akap450. Furthermore, ectopic expression of Nesprin-1a in undifferentiated myoblasts was also sufficient to target pericentriolar components to the nuclear envelope of some cells. One nice aspect of this study is that the authors confirmed their findings in differentiated myotubes from a clinical patient with a homozygous mutation in SYNE1 that truncates Nesprin-1a, causing muscular dystrophy [15] . Pericentrin, Akap450, and another component of the pericentriolar material (Pcm1) all failed to localize to the nuclear envelope in differentiated myotubes from the SYNE1 patient. Thus, Nesprin-1a is necessary and sufficient to recruit microtubule-nucleating proteins to the nuclear envelope in differentiating myoblasts.
The research next focused on determining whether disrupting the localization of pericentriolar material to the nuclear envelope affected nuclear spreading. In both diseased patient and C2C12 cultured myotubes treated with siRNA against Nesprin-1 or Akap450, nuclei failed to spread efficiently. Thus, disrupting the MTOC at the nuclear envelope causes a nuclear localization effect. These results led to a microtubule-nucleation model for nuclear spreading.
To test the microtubule-nucleating activity of the myotube nuclear envelope, Gimpel et al. [7] examined microtubule regrowth after depolymerization by nocodazole. Within 5 minutes of washing out the drug, microtubules rapidly grew from around the whole nuclear envelope of wild-type differentiating myotube nuclei. This regrowth failed in C2C12 cells depleted for Nesprin-1 or both SUN partners by siRNA and in SYNE1 mutant patient cells. These treatments did not disrupt longitudinal microtubules, suggesting that small puncta throughout the cytoplasm, as seen by pericentrin staining, served as MTOCs in the absence of Nesprin-1. Furthermore, the authors showed that Akap450, but not pericentrin, is the major player required for microtubule nucleation at the nuclear envelope. Thus, Nesprin-1a recruits pericentriolar material to the nuclear envelope, including Akap450, which functions through the g-tubulin ring complex to nucleate microtubules.
How does the microtubule-nucleation model fit with other characterized mechanisms for nuclear spreading (Figure 1) ? Previously, two models were proposed to drive nuclear spreading in myotubes. The first is a microtubulesliding model. The Gomes and Baylies labs showed that the microtubuleassociated protein MAP7/ensconsin crosslinks a microtubule to a tail of kinesin-1. Kinesin then reaches toward a second, anti-parallel microtubule and slides the two apart, resulting in nuclear spreading [18] . Since this mechanism functions at some distance from nuclei, it is likely that the microtubule-sliding model is compatible with the nuclear envelope microtubule-nucleation model. The second model is the cargo model. The Holzbaur lab showed that Nesprin-1 and Nesprin-2 recruit kinesin-1 to cargo -the nucleusthrough their LEWD motifs, which bind directly to kinesin light chains [19] . This model is distinct from the microtubulenucleation model because mutation of the LEWD motif in Nesprin-1a did not disrupt its microtubule-nucleation activity [7] .
To further determine the relative contribution of the microtubulenucleation model versus the cargo model, Gimpel et al. [7] developed a computational model for nuclear spreading in myotubes. The model included known parameters for microtubules, MTOCs on the surface of nuclei as well as in smaller puncta away from nuclei, kinesin-1 and dynein motors on the surface of nuclei, and MAP7/ kinesin-1 complexes for microtubule sliding. This model faithfully reproduced in silico simulations of nuclear spreading dynamics. When the microtubulenucleation activity of the nuclear envelope was removed from the model, nuclei were significantly less well spaced. When both microtubule-nucleation activity and kinesin-1 were removed from the nuclear envelope, nuclei became more clustered, suggesting these two mechanisms operate in parallel pathways and both are needed for the appropriate positioning of nuclei in myotubes.
In summary, this new study implicates a role for microtubule nucleation at the surface of the nuclear envelope for spreading nuclei in differentiating myotubes. Major remaining issues include the characterization of the role of microtubule nucleation in the other nuclear movements throughout muscle development, such as moving nuclei to the periphery of the myofiber [3] . Another outstanding question is to understand how nuclear positioning defects relate to pathologies of human diseases. Since such defects are correlated with diseased or damaged muscles, it is expected that the elucidation of mechanisms for nuclear positioning will lead to future translational research for the treatment of human muscular diseases. Nuclei (blue) spread apart in a developing myotube using three mechanisms. Nesprin-1/2 functions as a cargo adaptor for kinesin-1 (left inset). MAP7 and kinesin-1 slide antiparallel microtubules apart (center inset). Nesprin-1a recruits pericentriolar material to the nuclear envelope where it nucleates microtubules (right inset).
